Diagnosis and Management of Systemic Sclerosis in 2023
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (1 May 2023) | Viewed by 9851
Special Issue Editor
Special Issue Information
Dear Colleagues,
Systemic sclerosis is a devastating life-threatening autoimmune disease characterized by progressive vasculopathy, fibrosis, and immune dysregulation. Recently, experts in the field have utilized point-of-care tools as ways to diagnose patients with early systemic sclerosis, and to potentially monitor responses to treatment. With this, many experts have paid close attention to patients with very early diagnosis of systemic sclerosis (VeDoSS). There have also been various groups that have utilized combination therapies to treat VeDoSS patients. In this Special Issue, we would like to invite submissions that discuss various point-of-care tools that are utilized for risk stratifying VeDoSS patients, with an emphasis on how these tools are used to measure certain aspects of the pathogenesis. Similarly, we would also like to invite submissions that discuss the utility of combination therapies in SSc and how treatment using point of care tools is monitored, with an emphasis on how these approaches are utilized to improve and detect the various aspects driving the pathogenesis of SSc.
Dr. Mohammed S. Osman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnosis
- early systemic sclerosis
- combination therapies
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.